TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7895894

Group type: EXPERIMENTAL
Intervention: Alatop test
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Skin-prick test
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Total serum IgE determination
Number of subjects: 40
Study: 3312564

Group type: EXPERIMENTAL
Intervention: Cefoxitin
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Metronidazole plus amikacin
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Latamoxef
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Clindamycin plus amikacin
Number of subjects: 100
Study: 29266295

Group type: EXPERIMENTAL
Intervention: Supportive parenting profile
Number of subjects: 2876

Group type: EXPERIMENTAL
Intervention: Lukewarm parenting profile (14 & 24 months)
Number of subjects: 2876

Group type: EXPERIMENTAL
Intervention: Sufficient parenting profile (36 months and pre-K)
Number of subjects: 2876

Group type: EXPERIMENTAL
Intervention: Harsh parenting profile
Number of subjects: 2876

Group type: EXPERIMENTAL
Intervention: Detached parenting profile
Number of subjects: 2876

Group type: EXPERIMENTAL
Intervention: Depression and family conflict
Number of subjects: 2876
Study: 27101556

Group type: EXPERIMENTAL
Intervention: 50 mg saffron capsule (Crocus sativus L. stigma) twice daily for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo capsule twice daily for 12 weeks
Number of subjects: 60
Study: 24548574

Group type: COMPARATOR
Intervention: Obese women
Number of subjects: 160

Group type: COMPARATOR
Intervention: Women with abdominal obesity
Number of subjects: 160
Study: 21801467

Group type: EXPERIMENTAL
Intervention: Lingzhi (Ganoderma lucidum) 1.44 g daily for 12 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 20842389

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Multiple daily insulin injections (MDI)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Both CSII and MDI
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: CSII with insulin analogues
Number of subjects: 96
Study: 19211470

Group type: EXPERIMENTAL
Intervention: Education on avoiding foods with phosphorus additives
Number of subjects: 279

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 279
Study: 15718180

Group type: EXPERIMENTAL
Intervention: Nurse-led intervention involving patient and family education about heart failure and self-management, and monthly telephone follow-up during 12 months by a primary health care nurse
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 153
Study: 12855098

Group type: EXPERIMENTAL
Intervention: Lichtenstein tension‐free hernioplasty (LH)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Laparoscopic preperitoneal hernia (LPPH)
Number of subjects: 17
Study: 10596882

Group type: EXPERIMENTAL
Intervention: Amoxycillin and clavulanic acid for 1 week post tonsillectomy (Group A)
Number of subjects: 78

Group type: COMPARATOR
Intervention: No treatment (Group B)
Number of subjects: 78
Study: 8671790

Group type: EXPERIMENTAL
Intervention: Iloprost infusion (1 ng.kg-1.min-1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Iloprost infusion
Number of subjects: 10

Group type: COMPARATOR
Intervention: CsA ingestion (3 mg.kg-1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control clearance study without CsA intake or iloprost/placebo infusion
Number of subjects: 10
Study: 1877813

Group type: EXPERIMENTAL
Intervention: Intra-arterial infusion chemotherapy (IA)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Systemic chemotherapy (IV)
Number of subjects: 41
Study: 6635913

Group type: EXPERIMENTAL
Intervention: Povidone-iodine wound irrigation
Number of subjects: 187

Group type: COMPARATOR
Intervention: Normal saline solution
Number of subjects: 187
Study: 31843844

Group type: EXPERIMENTAL
Intervention: Nurse navigator-led ACP pathway
Number of subjects: 765

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 765
Study: 30080229

Group type: EXPERIMENTAL
Intervention: Investigational product (Cerbella TM) consisting of an emulsified liquid combination of standardized fish oil, panax ginseng extract, and green tea catechins
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Investigational product (Cerbella TM)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 26950257

Group type: EXPERIMENTAL
Intervention: Audio-based cognitive-behavioural therapy (CBT) program
Number of subjects: 24

Group type: COMPARATOR
Intervention: Waitlist control (WL)
Number of subjects: 24
Study: 24953481

Group type: EXPERIMENTAL
Intervention: Interpersonal Therapy (IPT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medication
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22098922

Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication (LNF)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Open Nissen fundoplication (ONF)
Number of subjects: 110
Study: 20180009

Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 226
Study: 17469154

Group type: EXPERIMENTAL
Intervention: Azithromycin (AZM)
Number of subjects: 0
Study: 15244014

Group type: EXPERIMENTAL
Intervention: PureSperm density gradient method
Number of subjects: 121

Group type: COMPARATOR
Intervention: Percoll density gradient method
Number of subjects: 121
Study: 11700918

Group type: EXPERIMENTAL
Intervention: Quality-of-life measurement using generic and specific instruments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality-of-life measurement using ad hoc instruments
Number of subjects: 0
Study: 10189587

Group type: EXPERIMENTAL
Intervention: BCG+ killed M. leprae
Number of subjects: 171400

Group type: EXPERIMENTAL
Intervention: ICRC
Number of subjects: 171400

Group type: EXPERIMENTAL
Intervention: M.w
Number of subjects: 171400

Group type: EXPERIMENTAL
Intervention: BCG
Number of subjects: 171400

Group type: COMPARATOR
Intervention: Normal saline placebo
Number of subjects: 171400
Study: 7827929

Group type: EXPERIMENTAL
Intervention: Ranitidine 100 mg IV twice daily for 4 days, followed by 150 mg orally twice daily for 5 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (no ranitidine)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 24
Study: 3396164

Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase
Number of subjects: 368
Study: 31109915

Group type: EXPERIMENTAL
Intervention: Integrated Stepped Alcohol Treatment (ISAT)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 128
Study: 28342828

Group type: EXPERIMENTAL
Intervention: Contralateral strength training (CST)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Direct strength training
Number of subjects: 30
Study: 26667739

Group type: EXPERIMENTAL
Intervention: 40 ml/day of extra virgin coconut oil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study: 23315144

Group type: EXPERIMENTAL
Intervention: Tibolone (various doses)
Number of subjects: 767
Study: 21252731

Group type: EXPERIMENTAL
Intervention: Repeated milking of the cord (four times)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Standard treatment (cord clamping for 30 seconds)
Number of subjects: 58
Study: 19724980

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 17882149

Group type: EXPERIMENTAL
Intervention: Highest tertile of fetuin-A levels
Number of subjects: 822

Group type: EXPERIMENTAL
Intervention: Fetuin-A as a continuous variable
Number of subjects: 822
Study: 15137930

Group type: EXPERIMENTAL
Intervention: Nutrition education intervention for 12 months
Number of subjects: 406

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 406
Study: 11822785

Group type: EXPERIMENTAL
Intervention: 600 mg clodronate
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 10181018

Group type: EXPERIMENTAL
Intervention: Computer-generated tailored letter on the outcomes of smoking cessation
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Computer-generated tailored letter containing self-efficacy enhancing information (skills)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Control condition (no cessation information)
Number of subjects: 246
Study: 8745495

Group type: EXPERIMENTAL
Intervention: Correction of abnormal fetal axis by hand in the study group (58 cases)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (30 cases)
Number of subjects: 108
Study: 2515724

Group type: EXPERIMENTAL
Intervention: Selegiline monotherapy
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 893725

Group type: EXPERIMENTAL
Intervention: Reliability Enhancement
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Truth Talk
Number of subjects: 57

Group type: COMPARATOR
Intervention: No Comment Control
Number of subjects: 57
Study: 31891746

Group type: COMPARATOR
Intervention: 300 mg resveratrol
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 1000 mg resveratrol
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 31220630

Group type: EXPERIMENTAL
Intervention: ERAS group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional care group
Number of subjects: 50
Study: 27594544

Group type: EXPERIMENTAL
Intervention: Suicide prevention program (twice a week for 5 weeks)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 62
Study: 26999890

Group type: EXPERIMENTAL
Intervention: Utility arches (UA)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mini-implants (MI)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 24459173

Group type: EXPERIMENTAL
Intervention: Prehab (exercise and education classes for 60 minutes/day, twice weekly for at least four weeks)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Prehab
Number of subjects: 17

Group type: COMPARATOR
Intervention: Standard care (three‐hour preassessment appointment)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 17
Study: 20884383

Group type: EXPERIMENTAL
Intervention: Clamping P(ET)(CO₂)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no clamping of P(ET)(CO₂))
Number of subjects: 10
Study: 18818954

Group type: EXPERIMENTAL
Intervention: Ceftibuten 9 mg/kg once daily for 10 days
Number of subjects: 547

Group type: COMPARATOR
Intervention: TMP‐SMX (3 mg + 15 mg)/kg twice daily for 10 days
Number of subjects: 547
Study: 17571655

Group type: COMPARATOR
Intervention: Hand immersion in 20 degrees C water
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Forearm immersion in 20 degrees C water
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Hand and forearm immersion in 10 degrees C water
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (no immersion)
Number of subjects: 6
Study: 15450766

Group type: EXPERIMENTAL
Intervention: 20% mannitol 100 ml IV in 20 min
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham infusion (control)
Number of subjects: 21
Study: 11473962

Group type: EXPERIMENTAL
Intervention: rhFSH 150 IU ('low')
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: rhFSH 225 IU ('high')
Number of subjects: 120
Study: 9608379

Group type: EXPERIMENTAL
Intervention: Thrust in Motion Cervical (TMC) manikin; experimental group (n = 6) practiced adjustive thrust only on the TMC manikin.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Established 'hands-on' approach; control group (n = 14) performed thrusting maneuvers on fellow student subjects.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups were supervised, taught and examined in an otherwise identical fashion.
Number of subjects: 20
Study: 8015241

Group type: EXPERIMENTAL
Intervention: Maxaquin 400 mg once a day for 7-14 days
Number of subjects: 62

Group type: COMPARATOR
Intervention: Ciprofloxacin 500 mg twice a day for 7-14 days
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Maxaquin
Number of subjects: 62

Group type: COMPARATOR
Intervention: Ciprofloxacin
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Maxaquin and Ciprofloxacin
Number of subjects: 62
Study: 2104811

Group type: EXPERIMENTAL
Intervention: Luteal phase supplementation with human chorionic gonadotropin (hCG) in Group A (n = 18)
Number of subjects: 36

Group type: COMPARATOR
Intervention: None (Control) in Group B (n = 18)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Luteal phase supplementation with hCG in Group A (n = 18)
Number of subjects: 36
Study: 71970

Group type: EXPERIMENTAL
Intervention: 200 mg flurbiprofen daily (tablet or liquid suspension)
Number of subjects: 40
Study: 31679055

Group type: EXPERIMENTAL
Intervention: Schizophrenia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bipolar Disorder
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alzheimer's Disease
Number of subjects: 0

Group type: COMPARATOR
Intervention: Genetic variants associated with schizophrenia, BD, and AD
Number of subjects: 0
Study: 31165663

Group type: EXPERIMENTAL
Intervention: Ticagrelor (180 mg loading dose)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Ticagrelor (90 mg BID for 30 days)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Clopidogrel (600 mg loading dose)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Clopidogrel (75 mg OD for 30 days)
Number of subjects: 117
Study: 28621488

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) for quadriceps muscle, 8 weeks, 3 times/week (20-34 min) during HD sessions
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 21
Study: 25922838

Group type: EXPERIMENTAL
Intervention: Long protocol with combined oral contraceptive (OC) pills
Number of subjects: 298

Group type: COMPARATOR
Intervention: Short agonist protocol with estradiol priming
Number of subjects: 298
Study: 24148574

Group type: EXPERIMENTAL
Intervention: Web based MMR decision aid plus usual practice
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: MMR leaflet plus usual practice
Number of subjects: 220

Group type: COMPARATOR
Intervention: Usual practice only (control)
Number of subjects: 220
Study: 21748205

Group type: EXPERIMENTAL
Intervention: 0.1 mcg/kg/min remifentanil infusion (Group R1)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: 0.15 mcg/kg/min remifentanil infusion (Group R2)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Both groups (R1 and R2)
Number of subjects: 86
Study: 19523012

Group type: EXPERIMENTAL
Intervention: Diphenhydramine (i.v. microdose 0.1 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diphenhydramine (oral microdose 0.1 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NBI‐2 (oral microdose 0.1 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NBI‐1 (oral microdose 0.1 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NBI‐3 (oral microdose 0.1 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NBI‐4 (oral microdose 0.1 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NBI‐4 (i.v. microdose 0.1 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NBI‐1 (i.v. microdose 0.1 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NBI‐3 (i.v. microdose 0.1 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NBI‐2 (i.v. microdose 0.1 mg)
Number of subjects: 0
Study: 16951472

Group type: EXPERIMENTAL
Intervention: Parathyroid hormone (PTH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PTH and raloxifene (combined treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Strontium ranelate
Number of subjects: 0
Study: 16382122

Group type: EXPERIMENTAL
Intervention: Tamoxifen 5 mg/d
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Fenretinide 200 mg/d
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Tamoxifen plus Fenretinide
Number of subjects: 235

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Fenretinide
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: All treatment arms
Number of subjects: 235
Study: 12730811

Group type: EXPERIMENTAL
Intervention: Water soluble vitamin E (100 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Tepid saline (control)
Number of subjects: 30
Study: 10503858

Group type: EXPERIMENTAL
Intervention: Face pad pressure dressing
Number of subjects: 47

Group type: COMPARATOR
Intervention: Traditional packing dressings
Number of subjects: 47
Study: 8952125

Group type: EXPERIMENTAL
Intervention: Muscle tense release
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Muscle stretch release
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cognitive relaxation procedures
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo attention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Test only control
Number of subjects: 30
Study: 2009249

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment (beta-blockers or diuretics)
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2000
Study: 7074750

Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg every 6 hours
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg every 6 hours
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Metoprolol 50 mg every 6 hours
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg every 6 hours
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31732852

Group type: EXPERIMENTAL
Intervention: Oral moisturizing jelly (OMJ)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Topical saliva gel (GC)
Number of subjects: 62
Study: 28844754

Group type: EXPERIMENTAL
Intervention: Intramuscular testosterone enanthate 2 mg/kg (group 2b)
Number of subjects: 200
Study: 28248037

Group type: EXPERIMENTAL
Intervention: Contact lithotripsy (URS)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave lithotripsy (ESWL)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Percutaneous nephrolithotomy (PNL)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combined lithotripsy (ESWL-URS)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 100
Study: 25909311

Group type: EXPERIMENTAL
Intervention: Transfusion with hemoglobin concentrations maintained above 9.0 g/dL (Group Hb9)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Withholding transfusion unless hemoglobin fell below 7.0 g/dL (Group Hb7)
Number of subjects: 46
Study: 23009800

Group type: EXPERIMENTAL
Intervention: Computer simulation videogame for eight sessions within 12 weeks
Number of subjects: 41

Group type: COMPARATOR
Intervention: Educational slides about treatment for AUD
Number of subjects: 41
Study: 19919580

Group type: COMPARATOR
Intervention: Intrarectal lidocaine gel (10 ml of 2% lidocaine)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Caudal block (20 ml 0.1% bupivacaine with 75 microg fentanyl)
Number of subjects: 100
Study: 19042837

Group type: EXPERIMENTAL
Intervention: 200 mcg octreotide
Number of subjects: 10

Group type: COMPARATOR
Intervention: 400 mcg hyoscine hydrobromide
Number of subjects: 10
Study: 16878325

Group type: EXPERIMENTAL
Intervention: CHOP (cyclophosphamide, vincristine, doxorubicin, and prednisone)
Number of subjects: 363

Group type: COMPARATOR
Intervention: MCP (mitoxantrone, chlorambucil, and prednisone)
Number of subjects: 363
Study: 12547870

Group type: EXPERIMENTAL
Intervention: Behavioral approach (counseling strategy)
Number of subjects: 340

Group type: COMPARATOR
Intervention: Usual care treatment (control)
Number of subjects: 340
Study: 10883420

Group type: EXPERIMENTAL
Intervention: Melatonin 2 mg intravenously
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Melatonin 2 mg orally
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Melatonin 4 mg orally
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 12
Study: 9535618

Group type: EXPERIMENTAL
Intervention: Chronic nitrate therapy
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no nitrate therapy)
Number of subjects: 29
Study: 8267871

Group type: EXPERIMENTAL
Intervention: Electric toothbrush
Number of subjects: 70

Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 70

Group type: COMPARATOR
Intervention: Both toothbrushes
Number of subjects: 70
Study: 3910582

Group type: EXPERIMENTAL
Intervention: Diuretics
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 29135482

Group type: EXPERIMENTAL
Intervention: Darapladib
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 26684822

Group type: EXPERIMENTAL
Intervention: RPV/FTC/TDF
Number of subjects: 799

Group type: COMPARATOR
Intervention: EFV/FTC/TDF
Number of subjects: 799
Study: 23860749

Group type: EXPERIMENTAL
Intervention: Calibrating orogastric tube insertion
Number of subjects: 60
Study: 22355040

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (5 mg/100 ml)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 20014118

Group type: EXPERIMENTAL
Intervention: Minocycline 200 mg/d
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Minocycline (n = 3)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo (n = 5)
Number of subjects: 63
Study: 19116709

Group type: EXPERIMENTAL
Intervention: Glycopyrronium bromide 0.4 mg every 6 hours for 12 hours
Number of subjects: 13

Group type: COMPARATOR
Intervention: Scopolamine hydrobromide 0.5 mg every 6 hours for 12 hours
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 13
Study: 15686289

Group type: EXPERIMENTAL
Intervention: Functional electrical stimulation (FES) applied during walking
Number of subjects: 8

Group type: COMPARATOR
Intervention: Walking without FES (phase A)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Walking with FES (phase B)
Number of subjects: 8